Cargando…
Maternal Obesity Does Not Exacerbate the Effects of LPS Injection on Pregnancy Outcomes in Mice
SIMPLE SUMMARY: Obesity increases the risk of problems during pregnancy, potentially due to inappropriate activation of the immune system. We predicted that, because of this immune activation, obesity in mice would exacerbate the effects of lipopolysaccharide (LPS), a substance that mimics infection...
Autores principales: | Virginkar, Natasha, Christians, Julian K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563678/ https://www.ncbi.nlm.nih.gov/pubmed/32947926 http://dx.doi.org/10.3390/biology9090293 |
Ejemplares similares
-
Pregnancy complications recur independently of maternal vascular malperfusion lesions
por: Christians, Julian K., et al.
Publicado: (2020) -
PAPP-A2 deficiency does not exacerbate the phenotype of a mouse model of intrauterine growth restriction
por: Christians, Julian K., et al.
Publicado: (2018) -
Altered placental expression of PAPPA2 does not affect birth weight in mice
por: Wagner, Pamela K, et al.
Publicado: (2010) -
Embryonic Development in Relation to Maternal Obesity Does Not Affect Pregnancy Outcomes in FET Cycles
por: Fawarseh, Adham, et al.
Publicado: (2022) -
Pappa2 deletion in mice affects male but not female fertility
por: Christians, Julian K., et al.
Publicado: (2015)